Myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitis without cerebral parenchyma involvement

Ren Changhong1, Liu Ming1, Zhou Anna1

  • 1Department of Neurology, National Center for Children'S Health, Beijing Children'S Hospital, Capital Medical University, No.56, Nan Li Shi Road, Beijing, 100045, China.

PubMed

Insights

Meningoencephalitis without brain involvement is an underrecognized form of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children. Early immunotherapy improves outcomes and reduces relapse risk in these MOGAD patients.

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Meningoencephalitis with meningeal involvement is a rare phenotype of MOGAD.
  • Previous reports were limited to case studies and small cohorts.

Purpose of the Study:

  • To analyze pediatric MOG antibody-associated meningoencephalitis cases without cerebral parenchymal involvement on imaging.
  • To characterize clinical presentation, diagnostic findings, and treatment outcomes.

Main Methods:

  • Retrospective analysis of MOG antibody-positive pediatric patients at Beijing Children's Hospital (2017-2024).
  • Included patients with meningoencephalitis but no parenchymal brain involvement on MRI.
  • Reviewed clinical data, laboratory results, imaging, and treatment responses.

Main Results:

  • Identified 18 pediatric patients (6% of MOGAD cohort) with this phenotype.
  • Common symptoms included fever, headache, and seizures; laboratory findings showed leukocytosis and elevated inflammatory markers.
  • Cranial MRI revealed meningeal enhancement in 14 patients; 4 had negative MRI scans.
  • Fourteen patients responded to immunotherapy after failing antibiotics; 22% experienced relapse, but all achieved good prognosis.

Conclusions:

  • Meningoencephalitis without parenchymal MRI findings is an underrecognized MOGAD phenotype in children.
  • Incorporating this entity into diagnostic criteria and early immunotherapy can improve diagnosis and reduce relapse risk.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...